Rebirth Globe Launches State-of-the-Art Regenerative Centers in China

September 30, 2024 06:17 PM AEST | By EIN Presswire
 Rebirth Globe Launches State-of-the-Art Regenerative Centers in China
Image source: EIN Presswire

Leading Regenerative Medicine, Rebirth Clinics Brings Innovative Anti-Aging Therapies to China HONG KONG, HONG KONG, HONG KONG, September 30, 2024 /EINPresswire.com/ -- Rebirth Globe., a global leader in regenerative medicine products and services, today announced the launch of two “Rebirth Clinics” China – In Beijing and Shanghai with the official launch date slated for Q1 2025. The launch enables Rebirth to meet increasing market demand for stem cell treatments and Anti-Aging Therapies in the greater China region.

Rebirth offers the highest-grade stem cell therapies available on the market -- Four day old MSC stem cells sourced from fresh umbilical cord tissue – In addition, Rebirth provides its own propriety regenerative products, including NAD+, DNA Test kits, an advanced Pelvic floor therapy chair and more.

“We are proud to be at the forefront of introducing revolutionary stem cell therapies to patients around the globe”, added Mr. Ronny Shany, Founder of Rebirth Globe, “This collaboration with Xuan Yang in China signifies a major leap in our mission to offer the most advanced medical treatments available anywhere in the world. By integrating Rebirth’s expertise in stem cell therapy, including our groundbreaking umbilical cord stem cells and regenerative treatments, we are set to redefine healthcare standards in China. Our commitment to excellence remains steadfast, even as we adapt to new developments and challenges in this pioneering area of healthcare”.

Rebirth Globe is a groundbreaking medical institute dedicated to transforming the landscape of advanced medical rejuvenation therapies using fresh Umbilical cord stem cells, IV treatments & more. As a leader in the regenerative medicine and the cellular therapy industry, Rebirth specializes in physician training certification, stem cell products, IV therapies, DNA testing & more, with its lead product, fresh Umbilical cord stem cells. In addition, the organization is involved with the creation and management of stem cell clinics around the world.

“We are thrilled to announce the expansion of Rebirth Clinics into China” said Xuan Yang, “This venture not only aligns with our commitment to healthcare innovation but also marks a significant step in making advanced regenerative medicine accessible in the region. Our collaboration with Rebirth is a testament to our dedication to bringing the latest in regenerative therapies and anti-aging treatments to our community. We envision a future where cutting-edge treatments like stem cell therapies become a cornerstone in modern healthcare. It took me less than 10 minutes to understand the potential of Rebirth in China, we are committed to adapting and growing in this dynamic field”.

“We are extremely happy to be expanding the rebirth brand Rebirth into China” said Derek Halpern, CMO of Rebirth Clinics, “This new venture aligns with our push to take our healthcare innovations around the world, and also is a pivotal step in bringing advanced regenerative medicine to the region of China; where we can help so many people. Derek also added, "We at Rebirth are in the driver’s seat at this interesting time of history, boldly moving healthcare to a more advanced state and proliferating the incredible benefits of regenerative therapies”.

Contact Details:

Derek Halpern
Svenson Network Holdings
+1 516-234-6564
email us here
Visit us on social media:
Facebook
X
LinkedIn
Instagram
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.